Derma Sciences Reports Results from DSC127 Pharmacokinetic Study Derma Sciences, Inc. , a medical device and pharmaceutical company focused on advanced wound care, announces that all data from the pharmacokinetic study with 0.03% DSC127 gel has been collected and analyzed.
June 12, 2013 - Business Wire via Yahoo! Finance
Derma Sciences reports positive results from Phase 1 diabetic foot ulcer study Derma Sciences announced that all data from the pharmacokinetic study with 0.03% DSC127 gel has been collected and analyzed. The open-label, single center, Phase 1 study enrolled 21 diabetic subjects with ...
June 12, 2013 - Theflyonthewall.com via Yahoo! Finance